Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Size and Structure of Viral Genomes01:26

Size and Structure of Viral Genomes

Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tumoricidal efficacy of DZ-1 dye conjugated to dihydroartemisinin in patient-derived colorectal liver metastasis tumoroids.

Molecular therapy. Oncology·2026
Same author

Linker-dependent variations in the tumoricidal activity of DZ-1-dihydroartemisinin conjugate formats.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

DZ-1-artesunate conjugate induces mitochondria-mediated, reactive oxygen species-dependent apoptosis in colorectal cancer tumoroids.

Frontiers in pharmacology·2026
Same author

Proximity labeling unveils potential roles of the Miro2-CISD1 network in mitochondrial dynamics and neuronal differentiation.

Communications biology·2026
Same author

DZ-1-Artesunate Induces Apoptosis Via a Bid-, Bax-, and Bak-Independent Caspase-3 Activation Pathway.

Journal of oncology research and therapy·2025
Same author

Distinct prognostic and molecular profiles of fat versus vein invasion in T3a renal cell carcinoma.

British journal of cancer·2025

Related Experiment Video

Updated: Jun 23, 2026

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants
15:49

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants

Published on: June 9, 2022

A novel program to design siRNAs simultaneously effective to highly variable virus genomes.

Hui Sun Lee1, Jeonghyun Ahn, Eun Jung Jun

  • 1Department of Physiology, University of Ulsan College of Medicine, Seoul, Republic of Korea.

Biochemical and Biophysical Research Communications
|May 9, 2009
PubMed
Summary

Designing effective antiviral therapies requires targeting conserved viral regions. A new bioinformatics tool, CAPSID, identifies these conserved sites for potent small interfering RNA (siRNA) design, demonstrating broad efficacy against Human enterovirus B serotypes.

More Related Videos

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

Bacterial Artificial Chromosomes: A Functional Genomics Tool for the Study of Positive-strand RNA Viruses
12:20

Bacterial Artificial Chromosomes: A Functional Genomics Tool for the Study of Positive-strand RNA Viruses

Published on: December 29, 2015

Related Experiment Videos

Last Updated: Jun 23, 2026

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants
15:49

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants

Published on: June 9, 2022

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

Bacterial Artificial Chromosomes: A Functional Genomics Tool for the Study of Positive-strand RNA Viruses
12:20

Bacterial Artificial Chromosomes: A Functional Genomics Tool for the Study of Positive-strand RNA Viruses

Published on: December 29, 2015

Area of Science:

  • Virology
  • Bioinformatics
  • RNA Interference

Background:

  • RNA viral genomes exhibit high sequence diversity and mutation rates, complicating antiviral therapy with small interfering RNAs (siRNAs).
  • Effective siRNA design necessitates targeting highly conserved genomic regions to ensure broad-spectrum antiviral activity.

Purpose of the Study:

  • To develop a novel bioinformatics program, CAPSID (Convenient Application Program for siRNA Design), for identifying siRNAs targeting conserved regions in RNA viral genomes.
  • To validate the efficacy of CAPSID-designed siRNAs against diverse Human enterovirus B (HEB) serotypes.

Main Methods:

  • CAPSID was designed to rapidly search for conserved patterns within diverse RNA viral sequences.
  • Input RNA sequences were analyzed to identify potential siRNA candidates targeting conserved regions.
  • Antiviral efficacy of selected HEB-specific siRNAs was assessed using Hela cells.

Main Results:

  • CAPSID successfully identified conserved patterns and suggested potent siRNA candidates.
  • HEB-specific siRNAs designed using CAPSID demonstrated protective effects against all tested HEB serotypes.
  • The results confirmed the broad-spectrum antiviral activity of the designed siRNAs.

Conclusions:

  • CAPSID is a valuable tool for designing universal antiviral siRNAs against highly divergent viral genomes.
  • Targeting conserved regions with CAPSID-designed siRNAs offers a promising strategy for combating RNA viral infections.
  • This approach has significant implications for developing broad-spectrum antiviral therapies.